Topical Dermatology Drug Developer Sol-Gel Inaugurates New Plant

Published: Dec 16, 2008

NESS ZIONA, Israel--(BUSINESS WIRE)--Sol Gel Technologies Ltd, a specialty pharmaceuticals company, today unveiled new state-of-the-art facilities for the development of innovative topical dermatology drugs. The new plant includes sophisticated research, development and analytical laboratories, pilot production facilities as well as management offices.

Back to news